{"schema_version":"alpha-governance-record-v2","alpha_id":"alpha:company:38a947b4-5251-4dcb-9f57-174e50c8457a","record_version":"public-1:ro-d751713988987e9331980363e24189ce","ontology_version":"alpha-governance-ontology-v1","as_of":"2026-10-24T04:46:48.115605+00:00","published_at":"2026-10-24T04:46:48.115605+00:00","section":"events","data":{"state":"PUBLISHED","derivation_version":"alpha-governance-event-derivation-v2","events":[{"event_id":"alpha:event:transition:17pwuxyyqfxjo","event_type":"CEO_CHANGED","effective_at":"2026-04-22","detected_at":"2026-10-24T04:46:48.115605+00:00","subject_ids":["alpha:person:david-h-mack-ph-d","alpha:company:38a947b4-5251-4dcb-9f57-174e50c8457a"],"caused_claim_ids":["alpha:claim:company:38a947b4-5251-4dcb-9f57-174e50c8457a:leadership_role:11"],"evidence_ids":["alpha:projection-evidence:document:2a7d03694bcf52d0e99db13bbad40c08b5e0c3af8770af15664f08f23ad4240a"],"summary":"David H. Mack, Ph.D. executive of PMV Pharmaceuticals, Inc., effective 2026-04-22.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:19q397suohxxm","event_type":"EXECUTIVE_APPOINTED","effective_at":"2026-04-22","detected_at":"2026-10-24T04:46:48.115605+00:00","subject_ids":["alpha:person:deepika-jalota-pharm-d","alpha:company:38a947b4-5251-4dcb-9f57-174e50c8457a"],"caused_claim_ids":["alpha:claim:company:38a947b4-5251-4dcb-9f57-174e50c8457a:leadership_role:12"],"evidence_ids":["alpha:projection-evidence:document:1f87eb9013b08edcdc12c3bbc9262cf83d3c4f4d8b0c7a77e8022db135fa1fb2"],"summary":"Deepika Jalota, Pharm.D. executive of PMV Pharmaceuticals, Inc., effective 2026-04-22.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1ql4bnj57voy9","event_type":"CFO_CHANGED","effective_at":"2026-04-22","detected_at":"2026-10-24T04:46:48.115605+00:00","subject_ids":["alpha:person:michael-carulli","alpha:company:38a947b4-5251-4dcb-9f57-174e50c8457a"],"caused_claim_ids":["alpha:claim:company:38a947b4-5251-4dcb-9f57-174e50c8457a:leadership_role:13"],"evidence_ids":["alpha:projection-evidence:document:71833d24bba19bca08a86c3bec506853e1819e44b85477fec135c84b9cdb83cb"],"summary":"Michael Carulli executive of PMV Pharmaceuticals, Inc., effective 2026-04-22.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:io5q9pp95j1f","event_type":"GC_CHANGED","effective_at":"2026-04-22","detected_at":"2026-10-24T04:46:48.115605+00:00","subject_ids":["alpha:person:robert-ticktin","alpha:company:38a947b4-5251-4dcb-9f57-174e50c8457a"],"caused_claim_ids":["alpha:claim:company:38a947b4-5251-4dcb-9f57-174e50c8457a:leadership_role:14"],"evidence_ids":["alpha:projection-evidence:document:0d901e668099e00fc5efc92c0889de5ece33552e48b6361fb1f8426b59256f9b"],"summary":"Robert Ticktin executive of PMV Pharmaceuticals, Inc., effective 2026-04-22.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1r8p4fpkt40yp","event_type":"DIRECTOR_APPOINTED","effective_at":"2022-01-01","detected_at":"2026-10-24T04:46:48.115605+00:00","subject_ids":["alpha:person:kirsten-flowers","alpha:company:38a947b4-5251-4dcb-9f57-174e50c8457a"],"caused_claim_ids":["alpha:claim:company:38a947b4-5251-4dcb-9f57-174e50c8457a:leadership_role:8"],"evidence_ids":["alpha:projection-evidence:document:1526a103969e53d781d323355f29a3e93d046d322510bb19ebe87a4b6a973a79"],"summary":"Kirsten Flowers seat on PMV Pharmaceuticals, Inc., effective 2022-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:810mgoq7l368","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2022-01-01","detected_at":"2026-10-24T04:46:48.115605+00:00","subject_ids":["alpha:person:kirsten-flowers","alpha:committee:pmv-pharmaceuticals-inc:audit"],"caused_claim_ids":["alpha:claim:company:38a947b4-5251-4dcb-9f57-174e50c8457a:committee_record:15"],"evidence_ids":["alpha:projection-evidence:4227f925ef169745d2f78150cdf592044c446656a925cf3c84c9c486ff752284"],"summary":"Kirsten Flowers member of Audit, effective 2022-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:m5zjym1722x1c","event_type":"DIRECTOR_APPOINTED","effective_at":"2021-01-01","detected_at":"2026-10-24T04:46:48.115605+00:00","subject_ids":["alpha:person:charles-m-baum-m-d-ph-d","alpha:company:38a947b4-5251-4dcb-9f57-174e50c8457a"],"caused_claim_ids":["alpha:claim:company:38a947b4-5251-4dcb-9f57-174e50c8457a:leadership_role:6"],"evidence_ids":["alpha:projection-evidence:document:1526a103969e53d781d323355f29a3e93d046d322510bb19ebe87a4b6a973a79"],"summary":"Charles M. Baum, M.D., Ph.D. seat on PMV Pharmaceuticals, Inc., effective 2021-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1nrmuz817jmza","event_type":"DIRECTOR_APPOINTED","effective_at":"2020-01-01","detected_at":"2026-10-24T04:46:48.115605+00:00","subject_ids":["alpha:person:laurie-stelzer","alpha:company:38a947b4-5251-4dcb-9f57-174e50c8457a"],"caused_claim_ids":["alpha:claim:company:38a947b4-5251-4dcb-9f57-174e50c8457a:leadership_role:9"],"evidence_ids":["alpha:projection-evidence:document:1526a103969e53d781d323355f29a3e93d046d322510bb19ebe87a4b6a973a79"],"summary":"Laurie Stelzer seat on PMV Pharmaceuticals, Inc., effective 2020-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1lm5b8i9ghdfm","event_type":"DIRECTOR_APPOINTED","effective_at":"2020-01-01","detected_at":"2026-10-24T04:46:48.115605+00:00","subject_ids":["alpha:person:richard-heyman-ph-d","alpha:company:38a947b4-5251-4dcb-9f57-174e50c8457a"],"caused_claim_ids":["alpha:claim:company:38a947b4-5251-4dcb-9f57-174e50c8457a:leadership_role:10"],"evidence_ids":["alpha:projection-evidence:document:1526a103969e53d781d323355f29a3e93d046d322510bb19ebe87a4b6a973a79"],"summary":"Richard Heyman, Ph.D. seat on PMV Pharmaceuticals, Inc., effective 2020-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1ppxxxg7bnb4u","event_type":"COMMITTEE_CREATED","effective_at":"2020-01-01","detected_at":"2026-10-24T04:46:48.115605+00:00","subject_ids":["alpha:committee:pmv-pharmaceuticals-inc:audit-chair","alpha:company:38a947b4-5251-4dcb-9f57-174e50c8457a"],"caused_claim_ids":["alpha:claim:company:38a947b4-5251-4dcb-9f57-174e50c8457a:leadership_role:9"],"evidence_ids":["alpha:projection-evidence:document:1526a103969e53d781d323355f29a3e93d046d322510bb19ebe87a4b6a973a79"],"summary":"Audit · Chair committee of PMV Pharmaceuticals, Inc., effective 2020-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:3hffjj1pi1xu7","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2020-01-01","detected_at":"2026-10-24T04:46:48.115605+00:00","subject_ids":["alpha:person:laurie-stelzer","alpha:committee:pmv-pharmaceuticals-inc:audit-chair"],"caused_claim_ids":["alpha:claim:company:38a947b4-5251-4dcb-9f57-174e50c8457a:leadership_role:9"],"evidence_ids":["alpha:projection-evidence:document:1526a103969e53d781d323355f29a3e93d046d322510bb19ebe87a4b6a973a79"],"summary":"Laurie Stelzer member of Audit · Chair, effective 2020-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1gwmmlicxolb2","event_type":"DIRECTOR_APPOINTED","effective_at":"2013-01-01","detected_at":"2026-10-24T04:46:48.115605+00:00","subject_ids":["alpha:person:arnold-levine-ph-d","alpha:company:38a947b4-5251-4dcb-9f57-174e50c8457a"],"caused_claim_ids":["alpha:claim:company:38a947b4-5251-4dcb-9f57-174e50c8457a:leadership_role:5"],"evidence_ids":["alpha:projection-evidence:document:1526a103969e53d781d323355f29a3e93d046d322510bb19ebe87a4b6a973a79"],"summary":"Arnold Levine, Ph.D. seat on PMV Pharmaceuticals, Inc., effective 2013-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:7t53fqcf97ig","event_type":"DIRECTOR_APPOINTED","effective_at":"2013-01-01","detected_at":"2026-10-24T04:46:48.115605+00:00","subject_ids":["alpha:person:david-h-mack-ph-d","alpha:company:38a947b4-5251-4dcb-9f57-174e50c8457a"],"caused_claim_ids":["alpha:claim:company:38a947b4-5251-4dcb-9f57-174e50c8457a:leadership_role:7"],"evidence_ids":["alpha:projection-evidence:document:1526a103969e53d781d323355f29a3e93d046d322510bb19ebe87a4b6a973a79"],"summary":"David H. Mack, Ph.D. seat on PMV Pharmaceuticals, Inc., effective 2013-01-01.","derivation":"temporal_relationship_change"}]},"claims":[{"id":"alpha:claim:company:38a947b4-5251-4dcb-9f57-174e50c8457a:leadership_role:5","subject_id":"alpha:company:38a947b4-5251-4dcb-9f57-174e50c8457a","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:arnold-levine-ph-d","object_label":"Arnold Levine, Ph.D.","object_source_name_forms":[],"value":"Arnold Levine, Ph.D.: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:arnold-levine-ph-d","name":"Arnold Levine, Ph.D."},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2013-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2013-01-01","valid_to":null,"recorded_at":"2026-10-24T04:46:48.115605+00:00","sources":[{"id":"alpha:projection-evidence:document:1526a103969e53d781d323355f29a3e93d046d322510bb19ebe87a4b6a973a79","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"PMV Pharmaceuticals, Inc. DEF 14A 2026-04-22","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1699382/000114036126016038/ny20064070x1_def14a.htm","source_date":"2026-04-22","retrieved_at":"2026-04-24T23:37:01.899+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-22","effective_from":"2013-01-01","effective_until":null,"observed_at":"2026-10-24T04:46:48.115605+00:00","reviewed_at":"2026-10-24T04:46:48.115605+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:38a947b4-5251-4dcb-9f57-174e50c8457a:leadership_role:6","subject_id":"alpha:company:38a947b4-5251-4dcb-9f57-174e50c8457a","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:charles-m-baum-m-d-ph-d","object_label":"Charles M. Baum, M.D., Ph.D.","object_source_name_forms":[],"value":"Charles M. Baum, M.D., Ph.D.: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:charles-m-baum-m-d-ph-d","name":"Charles M. Baum, M.D., Ph.D."},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2021-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2021-01-01","valid_to":null,"recorded_at":"2026-10-24T04:46:48.115605+00:00","sources":[{"id":"alpha:projection-evidence:document:1526a103969e53d781d323355f29a3e93d046d322510bb19ebe87a4b6a973a79","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"PMV Pharmaceuticals, Inc. DEF 14A 2026-04-22","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1699382/000114036126016038/ny20064070x1_def14a.htm","source_date":"2026-04-22","retrieved_at":"2026-04-24T23:37:01.899+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-22","effective_from":"2021-01-01","effective_until":null,"observed_at":"2026-10-24T04:46:48.115605+00:00","reviewed_at":"2026-10-24T04:46:48.115605+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:38a947b4-5251-4dcb-9f57-174e50c8457a:leadership_role:7","subject_id":"alpha:company:38a947b4-5251-4dcb-9f57-174e50c8457a","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:david-h-mack-ph-d","object_label":"David H. Mack, Ph.D.","object_source_name_forms":[],"value":"David H. Mack, Ph.D.: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:david-h-mack-ph-d","name":"David H. Mack, Ph.D."},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":false,"start_date":"2013-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2013-01-01","valid_to":null,"recorded_at":"2026-10-24T04:46:48.115605+00:00","sources":[{"id":"alpha:projection-evidence:document:1526a103969e53d781d323355f29a3e93d046d322510bb19ebe87a4b6a973a79","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"PMV Pharmaceuticals, Inc. DEF 14A 2026-04-22","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1699382/000114036126016038/ny20064070x1_def14a.htm","source_date":"2026-04-22","retrieved_at":"2026-04-24T23:37:01.899+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-22","effective_from":"2013-01-01","effective_until":null,"observed_at":"2026-10-24T04:46:48.115605+00:00","reviewed_at":"2026-10-24T04:46:48.115605+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:38a947b4-5251-4dcb-9f57-174e50c8457a:leadership_role:8","subject_id":"alpha:company:38a947b4-5251-4dcb-9f57-174e50c8457a","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:kirsten-flowers","object_label":"Kirsten Flowers","object_source_name_forms":[],"value":"Kirsten Flowers: Director, Audit","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:kirsten-flowers","name":"Kirsten Flowers"},"title":"Director","role_category":"director","committee":"Audit","is_board_chair":false,"is_independent":true,"start_date":"2022-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2022-01-01","valid_to":null,"recorded_at":"2026-10-24T04:46:48.115605+00:00","sources":[{"id":"alpha:projection-evidence:document:1526a103969e53d781d323355f29a3e93d046d322510bb19ebe87a4b6a973a79","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"PMV Pharmaceuticals, Inc. DEF 14A 2026-04-22","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1699382/000114036126016038/ny20064070x1_def14a.htm","source_date":"2026-04-22","retrieved_at":"2026-04-24T23:37:01.899+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-22","effective_from":"2022-01-01","effective_until":null,"observed_at":"2026-10-24T04:46:48.115605+00:00","reviewed_at":"2026-10-24T04:46:48.115605+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:38a947b4-5251-4dcb-9f57-174e50c8457a:leadership_role:9","subject_id":"alpha:company:38a947b4-5251-4dcb-9f57-174e50c8457a","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:laurie-stelzer","object_label":"Laurie Stelzer","object_source_name_forms":[],"value":"Laurie Stelzer: Director, Audit · Chair","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:laurie-stelzer","name":"Laurie Stelzer"},"title":"Director","role_category":"director","committee":"Audit · Chair","is_board_chair":false,"is_independent":true,"start_date":"2020-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2020-01-01","valid_to":null,"recorded_at":"2026-10-24T04:46:48.115605+00:00","sources":[{"id":"alpha:projection-evidence:document:1526a103969e53d781d323355f29a3e93d046d322510bb19ebe87a4b6a973a79","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"PMV Pharmaceuticals, Inc. DEF 14A 2026-04-22","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1699382/000114036126016038/ny20064070x1_def14a.htm","source_date":"2026-04-22","retrieved_at":"2026-04-24T23:37:01.899+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-22","effective_from":"2020-01-01","effective_until":null,"observed_at":"2026-10-24T04:46:48.115605+00:00","reviewed_at":"2026-10-24T04:46:48.115605+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:38a947b4-5251-4dcb-9f57-174e50c8457a:leadership_role:10","subject_id":"alpha:company:38a947b4-5251-4dcb-9f57-174e50c8457a","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:richard-heyman-ph-d","object_label":"Richard Heyman, Ph.D.","object_source_name_forms":[],"value":"Richard Heyman, Ph.D.: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:richard-heyman-ph-d","name":"Richard Heyman, Ph.D."},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2020-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2020-01-01","valid_to":null,"recorded_at":"2026-10-24T04:46:48.115605+00:00","sources":[{"id":"alpha:projection-evidence:document:1526a103969e53d781d323355f29a3e93d046d322510bb19ebe87a4b6a973a79","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"PMV Pharmaceuticals, Inc. DEF 14A 2026-04-22","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1699382/000114036126016038/ny20064070x1_def14a.htm","source_date":"2026-04-22","retrieved_at":"2026-04-24T23:37:01.899+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-22","effective_from":"2020-01-01","effective_until":null,"observed_at":"2026-10-24T04:46:48.115605+00:00","reviewed_at":"2026-10-24T04:46:48.115605+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:38a947b4-5251-4dcb-9f57-174e50c8457a:leadership_role:11","subject_id":"alpha:company:38a947b4-5251-4dcb-9f57-174e50c8457a","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:david-h-mack-ph-d","object_label":"David H. Mack, Ph.D.","object_source_name_forms":[],"value":"David H. Mack, Ph.D.: President, Chief Executive Officer and Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:david-h-mack-ph-d","name":"David H. Mack, Ph.D."},"title":"President, Chief Executive Officer and Director","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-04-22","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-04-22","valid_to":null,"recorded_at":"2026-10-24T04:46:48.115605+00:00","sources":[{"id":"alpha:projection-evidence:document:2a7d03694bcf52d0e99db13bbad40c08b5e0c3af8770af15664f08f23ad4240a","identity_scope":"source_document_reference","source_type":"sec_filing","title":"PMVP DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1699382/000114036126016038/ny20064070x1_def14a.htm","source_date":"2026-04-22T00:00:00+00:00","retrieved_at":"2026-05-16T07:02:04.658217+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-22T00:00:00+00:00","effective_from":"2026-04-22","effective_until":null,"observed_at":"2026-10-24T04:46:48.115605+00:00","reviewed_at":"2026-10-24T04:46:48.115605+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:38a947b4-5251-4dcb-9f57-174e50c8457a:leadership_role:12","subject_id":"alpha:company:38a947b4-5251-4dcb-9f57-174e50c8457a","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:deepika-jalota-pharm-d","object_label":"Deepika Jalota, Pharm.D.","object_source_name_forms":[],"value":"Deepika Jalota, Pharm.D.: Chief Development Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:deepika-jalota-pharm-d","name":"Deepika Jalota, Pharm.D."},"title":"Chief Development Officer","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-04-22","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-04-22","valid_to":null,"recorded_at":"2026-10-24T04:46:48.115605+00:00","sources":[{"id":"alpha:projection-evidence:document:1f87eb9013b08edcdc12c3bbc9262cf83d3c4f4d8b0c7a77e8022db135fa1fb2","identity_scope":"source_document_reference","source_type":"sec_filing","title":"PMVP DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1699382/000114036126016038/ny20064070x1_def14a.htm","source_date":"2026-04-22T00:00:00+00:00","retrieved_at":"2026-05-16T07:02:05.845396+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-22T00:00:00+00:00","effective_from":"2026-04-22","effective_until":null,"observed_at":"2026-10-24T04:46:48.115605+00:00","reviewed_at":"2026-10-24T04:46:48.115605+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:38a947b4-5251-4dcb-9f57-174e50c8457a:leadership_role:13","subject_id":"alpha:company:38a947b4-5251-4dcb-9f57-174e50c8457a","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:michael-carulli","object_label":"Michael Carulli","object_source_name_forms":[],"value":"Michael Carulli: Chief Financial Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:michael-carulli","name":"Michael Carulli"},"title":"Chief Financial Officer","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-04-22","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-04-22","valid_to":null,"recorded_at":"2026-10-24T04:46:48.115605+00:00","sources":[{"id":"alpha:projection-evidence:document:71833d24bba19bca08a86c3bec506853e1819e44b85477fec135c84b9cdb83cb","identity_scope":"source_document_reference","source_type":"sec_filing","title":"PMVP DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1699382/000114036126016038/ny20064070x1_def14a.htm","source_date":"2026-04-22T00:00:00+00:00","retrieved_at":"2026-05-16T07:02:05.256425+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-22T00:00:00+00:00","effective_from":"2026-04-22","effective_until":null,"observed_at":"2026-10-24T04:46:48.115605+00:00","reviewed_at":"2026-10-24T04:46:48.115605+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:38a947b4-5251-4dcb-9f57-174e50c8457a:leadership_role:14","subject_id":"alpha:company:38a947b4-5251-4dcb-9f57-174e50c8457a","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:robert-ticktin","object_label":"Robert Ticktin","object_source_name_forms":[],"value":"Robert Ticktin: General Counsel and Chief Operating Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:robert-ticktin","name":"Robert Ticktin"},"title":"General Counsel and Chief Operating Officer","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-04-22","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-04-22","valid_to":null,"recorded_at":"2026-10-24T04:46:48.115605+00:00","sources":[{"id":"alpha:projection-evidence:document:0d901e668099e00fc5efc92c0889de5ece33552e48b6361fb1f8426b59256f9b","identity_scope":"source_document_reference","source_type":"sec_filing","title":"PMVP DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1699382/000114036126016038/ny20064070x1_def14a.htm","source_date":"2026-04-22T00:00:00+00:00","retrieved_at":"2026-05-16T07:02:06.459559+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-22T00:00:00+00:00","effective_from":"2026-04-22","effective_until":null,"observed_at":"2026-10-24T04:46:48.115605+00:00","reviewed_at":"2026-10-24T04:46:48.115605+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:38a947b4-5251-4dcb-9f57-174e50c8457a:committee_record:15","subject_id":"alpha:company:38a947b4-5251-4dcb-9f57-174e50c8457a","predicate":"alpha:hasBoardCommittee","object_id":null,"object_label":null,"object_source_name_forms":[],"value":"Audit: Chair Laurie Stelzer; Members Laurie Stelzer (Chair); Kirsten Flowers","claim_type":"committee_record","predicate_id":"alpha:predicate:committee_record","predicate_version":1,"machine_key":"committee_record","human_label":"Committee Record","governed_predicate":true,"machine_value":{"name":"Audit","canonical_type":"audit","chair":"Laurie Stelzer","members":[{"display_name":"Laurie Stelzer","person_slug":"laurie-stelzer","is_chair":true},{"display_name":"Kirsten Flowers","person_slug":"kirsten-flowers","is_chair":false}],"source_id":"board_seats"},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-24T04:46:48.115605+00:00","sources":[{"id":"alpha:projection-evidence:4227f925ef169745d2f78150cdf592044c446656a925cf3c84c9c486ff752284","identity_scope":"representation_reference","source_type":"board_seats","title":"Audit","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/1699382/000114036126016038/ny20064070x1_def14a.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-24T04:46:48.115605+00:00","reviewed_at":"2026-10-24T04:46:48.115605+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"}],"evidence":[{"id":"alpha:projection-evidence:document:1526a103969e53d781d323355f29a3e93d046d322510bb19ebe87a4b6a973a79","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"PMV Pharmaceuticals, Inc. DEF 14A 2026-04-22","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1699382/000114036126016038/ny20064070x1_def14a.htm","source_date":"2026-04-22","retrieved_at":"2026-04-24T23:37:01.899+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:2a7d03694bcf52d0e99db13bbad40c08b5e0c3af8770af15664f08f23ad4240a","identity_scope":"source_document_reference","source_type":"sec_filing","title":"PMVP DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1699382/000114036126016038/ny20064070x1_def14a.htm","source_date":"2026-04-22T00:00:00+00:00","retrieved_at":"2026-05-16T07:02:04.658217+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:1f87eb9013b08edcdc12c3bbc9262cf83d3c4f4d8b0c7a77e8022db135fa1fb2","identity_scope":"source_document_reference","source_type":"sec_filing","title":"PMVP DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1699382/000114036126016038/ny20064070x1_def14a.htm","source_date":"2026-04-22T00:00:00+00:00","retrieved_at":"2026-05-16T07:02:05.845396+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:71833d24bba19bca08a86c3bec506853e1819e44b85477fec135c84b9cdb83cb","identity_scope":"source_document_reference","source_type":"sec_filing","title":"PMVP DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1699382/000114036126016038/ny20064070x1_def14a.htm","source_date":"2026-04-22T00:00:00+00:00","retrieved_at":"2026-05-16T07:02:05.256425+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:0d901e668099e00fc5efc92c0889de5ece33552e48b6361fb1f8426b59256f9b","identity_scope":"source_document_reference","source_type":"sec_filing","title":"PMVP DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1699382/000114036126016038/ny20064070x1_def14a.htm","source_date":"2026-04-22T00:00:00+00:00","retrieved_at":"2026-05-16T07:02:06.459559+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:4227f925ef169745d2f78150cdf592044c446656a925cf3c84c9c486ff752284","identity_scope":"representation_reference","source_type":"board_seats","title":"Audit","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/1699382/000114036126016038/ny20064070x1_def14a.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"coverage_state":"PUBLISHED","quality":{"schema_version":"alpha-record-quality-v2","overall":0.844,"status":"strong","publication_readiness":"ready","dimensions":{"identity":1,"coverage":0.5,"freshness":1,"evidence_completeness":1,"source_authority":0.847,"cross_source_agreement":0.75,"temporal_completeness":0.833},"diagnostics":{"published_claims":17,"factual_claims":17,"claims_with_linked_evidence":17,"disputed_claims":0,"conflicts":0,"stale_claims":0,"stale_claim_ids":[],"temporal_claims":12,"temporal_claims_with_valid_from":10,"missing_coverage_sections":["governance","financials","workforce","ownership","ratings"],"missing_expected_claims":["headquarters","official_website","financial_metric","governance_document","ownership","auditor","legal_matter","risk","ai_governance"]},"derivation":"deterministic_record_projection"},"publication":{"state":"PUBLISHED","published_at":"2026-10-24T04:46:48.115605+00:00","observed_at":"2026-10-24T04:46:48.115605+00:00","reviewed_at":"2026-10-24T04:46:48.115605+00:00","verified_at":"2026-10-24T04:46:48.115605+00:00"},"verification":{"schema_version":"alpha-verification-states-v1","state":"source_reported","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":17,"corroborated":0,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"Published claims are reported by public sources; none is Alpha verified. Profile ownership is unclaimed.","facets":[{"facet":"identity","state":"unclaimed"},{"facet":"evidence","state":"source_reported"},{"facet":"evaluation","state":"not_evaluated"},{"facet":"monitoring","state":null},{"facet":"authority","state":null},{"facet":"freshness","state":"current"}]},"rights":{"public_retrieval":"allowed","agent_retrieval":"allowed","redistribution":"not_granted","model_training":"not_granted","commercial_use":"not_specified","relationship_pathfinding":"not_granted","direct_contact":"not_granted"},"resource":{"uri":"alpha://company/pmv-pharmaceuticals-inc/events","section":"events","href":"https://registry.alpha.ac/api/public/companies/pmv-pharmaceuticals-inc?format=record&section=events","media_type":"application/json","availability":"contract"},"limitations":["Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.","Only explicitly published canonical company identity and current confirmed public roles are included.","Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.","Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.","This Company Profile is an identity and evidence record, not an Alpha rating."]}